Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A

Author： Groen Emma J. Charlton Richard Barresi Rita Anderson Louise V. Eagle Michelle Hudson Judith Koref Mauro Santibanez Straub Volker Bushby Katharine M. D.

Publisher： Oxford University Press

ISSN： 1460-2156

Source： Brain, Vol.130, Iss.12, 2007-12, pp. : 3237-3249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epilepsy and limb girdle muscular dystrophy type 2A: double trouble, serendipitous finding or new phenotype?

By Pizzanelli C. Mancuso M. Galli R. Choub A. Fanin M. Nascimbeni A. Siciliano G. Murri L.

Neurological Sciences, Vol. 27, Iss. 2, 2006-06 ,pp. : 134-137

Springer Publishing Company

Access to resources Recommend Favorite

A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy

By Hicks Debbie

Brain, Vol. 134, Iss. 1, 2011-01 ,pp. : 171-182

Oxford University Press

Access to resources Recommend Favorite

Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain)

By Urtasun M Sáenz A Roudaut C Poza JJ Urtizberea JA Cobo AM Richard I García Bragado F Leturcq F Kaplan JC Martí Massó JF Beckmann JS López de Munain A

Brain, Vol. 121, Iss. 9, 1998-09 ,pp. : 1735-1747

Oxford University Press

Access to resources Recommend Favorite

Dysferlin protein analysis in limb-girdle muscular dystrophies

By Vainzof Mariz Anderson Louise McNally Elizabeth Davis Dawn Faulkner Georgine Valle Giorgio Moreira Eloisa Pavanello Rita Passos-Bueno Maria Zatz Mayana

Journal of Molecular Neuroscience, Vol. 17, Iss. 1, 2001-08 ,pp. : 71-80

Humana Press, Inc

Access to resources Recommend Favorite

A phase I trial of adeno-associated virus serotype 1--sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C

By Herson Serge

Brain, Vol. 135, Iss. 2, 2012-03 ,pp. : 483-492

Oxford University Press

Access to resources Recommend Favorite